封面
市場調查報告書
商品編碼
2141392

蛋清蛋白水解物市場機會、成長要素、產業趨勢分析及2026-2035年預測

Egg Protein Hydrolysates Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026 - 2035

出版日期: | 出版商: Global Market Insights Inc. | 英文 180 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

全球雞蛋蛋白水解物市場預計到 2025 年將價值 2.42 億美元,年複合成長率為 6.4%,到 2035 年將達到 4.449 億美元。

市場範圍
開始年份 2025
預測期 2026-2035
初始市場規模 2.42億美元
預計金額 4.449億美元
複合年成長率 6.4%

預計市場規模將從2025年的15,800千噸增加到2035年的25,700千噸。隨著食品和營養產業從傳統的雞蛋加工轉向高附加價值的功能性成分,雞蛋蛋白水解物的商業性重要性日益凸顯。其市場潛力不僅取決於蛋白質含量,還取決於用於將蛋白質分解成更短胜肽鏈的控制水解過程。這種加工技術可以改善特定配方中的消化率、溶解度和功能性。消費者對高蛋白營養、功能性成分、運動營養和特殊膳食產品的興趣日益濃厚,推動了對雞蛋來源肽類成分的需求。製造商也致力於研發能夠實現胜肽特性和應用性能一致性的加工技術。成熟的雞蛋加工基礎設施,加上對高品質營養成分日益成長的需求,正在為食品、膳食補充劑和臨床營養領域創造新的機會。隨著原料開發商不斷最佳化水解過程並擴大商業配方,預計到 2035 年,蛋清蛋白水解物將在更廣泛的應用領域中得到應用。

預計到2025年,蛋清水解物市場規模將達到1.077億美元,並在2035年之前以6.3%的複合年成長率成長。蛋清蛋白為開發具有各種功能特性的胜肽基原料提供了多樣化的基礎。其營養成分和加工靈活性使其在特種配方中持續應用。對蛋清水解物的研究表明,其吸收迅速,使其在運動營養和臨床營養應用中保持重要地位。胜肽配方的持續開發以及對易消化蛋白質原料日益成長的需求預計將在整個預測期內推動該細分市場的成長。

預計2025年,營養保健品應用領域市場規模將達6,780萬美元,2035年將達到1.198億美元。蛋源胜肽組分被添加到營養保健品配方中,用於促進消化健康、增強免疫力、維護心血管健康、抗氧化和抗發炎。消費者對功能性營養和健康成分日益成長的興趣,為蛋蛋白水解物在營養保健品領域創造了更多機會。

預計到2025年,北美蛋清蛋白水解物市場規模將達到9,560萬美元。其中,美國市場規模預計為6,090萬美元,這得益於其成熟的分銷和配方管道,服務於運動營養、機能飲料、膳食補充劑和臨床營養等領域。此外,完善的蛋白加工供應鏈也保障了原料的穩定供應,而加拿大則補充了區域加工能力,並促進了以出口為導向的原料貿易。

目錄

第1章:調查方法

第2章執行摘要

第3章 行業洞察

  • 產業生態系分析
    • 供應商情況
    • 利潤率
    • 每個階段增加的價值
    • 影響價值鏈的因素
    • 中斷
  • 影響產業的因素
    • 促進因素
    • 產業潛在風險與挑戰
    • 市場機遇
  • 成長潛力分析
  • 監理情勢
  • 波特的分析
  • PESTLE分析
  • 價格趨勢
    • 按地區
  • 未來市場趨勢
  • 技術與創新展望
    • 最新科技趨勢
    • 新興技術
  • 專利趨勢
  • 貿易統計資料(註:貿易統計僅包含主要國家的資料)
    • 主要進口國
    • 主要出口國
  • 永續性和環境方面
    • 永續計劃
    • 減少廢棄物策略
    • 生產中的能源效率
    • 具有環保意識的舉措
  • 考慮碳足跡

第4章 競爭情勢

  • 介紹
  • 企業市佔率分析
    • 按地區
      • 北美洲
      • 歐洲
      • 亞太地區
      • LATAM
      • 中東和非洲
  • 企業矩陣分析
  • 主要市場公司的競爭分析
  • 競爭定位矩陣
  • 主要進展
    • 併購
    • 夥伴關係和聯盟
    • 新產品發布
    • 業務拓展計劃

第5章 市場估計與預測:依來源類型分類,2025-2035年

  • 蛋清水解物
    • 高純度蛋白質製劑
    • 減少過敏原的產品
  • 蛋黃水解物
    • 富含磷脂的胜肽
    • 脂蛋白功能混合物
  • 全蛋水解物
    • 均衡的胺基酸組成
    • 通用配方

第6章 市場估價與預測:依製程分類,2025-2035年

  • 酵素水解
  • 酸水解
  • 其他方法

第7章 市場估計與預測:依形式分類,2025-2035年

  • 粉末
  • 液體
  • 膠囊/片劑

第8章 市場估計與預測:依應用領域分類,2025-2035年

  • 營養保健品
    • 消化系統健康
    • 免疫支持
    • 抗發炎功能
  • 運動營養
    • 運動前產品
    • 運動後恢復產品
    • 肌肉恢復胜肽
  • 嬰幼兒和老年人的營養
    • 低致敏蛋白混合物
    • 易於消化吸收的氨基酸組成
  • 臨床營養
    • 腸內營養液
    • 恢復飲食
  • 功能性食品和飲料
    • 烘焙混合料
    • 乳製品及非乳製品飲料
  • 化妝品和個人護理
    • 抗衰老護膚
    • 保濕用途
    • 屏障修復配方

第9章 市場估計與預測:依地區分類,2025-2035年

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳洲
    • 韓國
    • 其他亞太國家
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 其他拉丁美洲國家
  • 中東和非洲
    • 沙烏地阿拉伯
    • 南非
    • UAE
    • 其他中東和非洲國家

第10章:公司簡介

  • Kewpie Corporation
  • Bouwhuis Enthoven BV
  • Merck KGaA
  • Rose Acre Farms
  • Rembrandt Foods
  • Sanovo Technology Group
  • Ovostar Union
  • Pulviver
  • IGRECA
  • Taiyo Kagaku Co., Ltd.
  • Bioseutica
  • Deb-El Food Products
  • AgroAlta
  • EW Group
  • Ballas Egg
  • Eurovo Srl
  • Crystal Lake Farms
  • Farm Pride Foods
  • Dalian Hanovo Foods
  • SOVIMO HELLAS SA
簡介目錄
Product Code: 15263

The Global Egg Protein Hydrolysates Market was valued at USD 242 million in 2025 and is estimated to grow at a CAGR of 6.4% to reach USD 444.9 million by 2035.

Market Scope
Start Year2025
Forecast Year2026-2035
Start Value$242 Million
Forecast Value$444.9 Million
CAGR6.4%

Market volume is projected to increase from 15,800 kilo tons in 2025 to 25,700 kilo tons by 2035. Egg protein hydrolysates are gaining commercial importance as the food and nutrition industries move beyond conventional egg processing toward higher-value functional ingredients. Their market potential depends not only on their protein content but also on the controlled hydrolysis process used to break proteins into shorter peptide chains. This processing approach can improve digestibility, solubility, and functionality for targeted formulations. Growing consumer interest in protein-rich nutrition, functional ingredients, sports nutrition, and specialized dietary products is supporting demand for egg-derived peptide ingredients. Manufacturers are also focusing on processing technologies that can deliver consistent peptide characteristics and application performance. The combination of established egg-processing infrastructure and increasing demand for premium nutritional ingredients is creating opportunities across food, supplement, and clinical nutrition applications. As ingredient developers continue to optimize hydrolysis processes and expand commercial formulations, egg protein hydrolysates are expected to gain broader use through 2035.

Egg white hydrolysates segment held USD 107.7 million in 2025 and is forecast to grow at a CAGR of 6.3% through 2035. Egg white proteins provide a diverse foundation for developing peptide-based ingredients with different functional characteristics. Their nutritional profile and processing versatility continue to support their use in specialized formulations. Research on egg white hydrolysates has highlighted their potential for rapid absorption, which maintains their relevance across sports nutrition and clinical nutrition applications. Continued development of peptide formulations and increasing demand for easily digestible protein ingredients are expected to support segment growth during the forecast period.

Nutraceutical applications segment recorded USD 67.8 million in 2025 and is expected to reach USD 119.8 million by 2035. Egg-derived peptide fractions are incorporated into nutraceutical formulations designed around digestive health, immune support, cardiovascular wellness, antioxidant properties, and anti-inflammatory benefits. Increasing consumer interest in functional nutrition and health-focused ingredients is creating additional opportunities for egg protein hydrolysates within the nutraceutical sector.

North America Egg Protein Hydrolysates Market captured USD 95.6 million in 2025. The United States generated USD 60.9 million in 2025 and benefits from well-established distribution and formulation channels serving sports nutrition, functional beverages, dietary supplements, and clinical nutrition. Integrated egg-processing supply chains also support reliable access to feedstock, while Canada adds regional processing capabilities and contributes to export-focused ingredient trade.

Major companies operating in the global Egg Protein Hydrolysates market include Taiyo Kagaku Co. Ltd., Merck KGaA, Kewpie Corporation, IGRECA, and Rembrandt Foods. Companies in the global Egg Protein Hydrolysates market are strengthening their market foothold through product development, processing technology improvements, capacity expansion, strategic partnerships, and broader distribution networks. Manufacturers are investing in hydrolysis technologies that can improve peptide consistency, solubility, digestibility, and functionality across different formulations. Expanding product portfolios allows companies to address demand from nutraceutical, sports nutrition, clinical nutrition, and functional food applications. Strategic collaborations with food manufacturers, supplement brands, ingredient distributors, and research organizations are helping businesses accelerate formulation development and increase market access. Companies are also optimizing egg-processing and peptide-production operations to improve yields, quality control, and cost efficiency. Geographic expansion is supporting access to new customers and emerging nutrition markets. In addition, businesses are emphasizing technical support, customized ingredient solutions, regulatory compliance, and reliable supply capabilities to build long-term B2B relationships and strengthen their competitive positions.

Table of Contents

Chapter 1. Methodology

  • 1.1 Market scope and definition
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Data mining sources
    • 1.3.1 Global
    • 1.3.2 Regional/Country
  • 1.4 Base estimates and calculations
    • 1.4.1 Base year calculation
    • 1.4.2 Key trends for market estimation
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
  • 1.6 Forecast model
  • 1.7 Research assumptions and limitations

Chapter 2. Executive Summary

  • 2.1 Industry 360° synopsis
  • 2.2 Key market trends
    • 2.2.1 Regional
    • 2.2.2 Source Type
    • 2.2.3 Process
    • 2.2.4 Form
    • 2.2.5 Application
  • 2.3 TAM Analysis, 2025-2035
  • 2.4 CXO perspectives: Strategic imperatives
    • 2.4.1 Executive decision points
    • 2.4.2 Critical success factors
  • 2.5 Future Outlook and Strategic Recommendations

Chapter 3. Industry Insights

  • 3.1 Industry ecosystem analysis
    • 3.1.1 Supplier Landscape
    • 3.1.2 Profit Margin
    • 3.1.3 Value addition at each stage
    • 3.1.4 Factor affecting the value chain
    • 3.1.5 Disruptions
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
    • 3.2.2 Industry pitfalls and challenges
    • 3.2.3 Market opportunities
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
    • 3.4.1 North America
    • 3.4.2 Europe
    • 3.4.3 Asia Pacific
    • 3.4.4 Latin America
    • 3.4.5 Middle East & Africa
  • 3.5 Porter’s analysis
  • 3.6 PESTEL analysis
  • 3.7 Price trends
    • 3.7.1 By region
  • 3.8 Future market trends
  • 3.9 Technology and Innovation landscape
    • 3.9.1 Current technological trends
    • 3.9.2 Emerging technologies
  • 3.10 Patent Landscape
  • 3.11 Trade statistics (Note: the trade statistics will be provided for key countries only)
    • 3.11.1 Major importing countries
    • 3.11.2 Major exporting countries
  • 3.12 Sustainability and Environmental Aspects
    • 3.12.1 Sustainable Practices
    • 3.12.2 Waste Reduction Strategies
    • 3.12.3 Energy Efficiency in Production
    • 3.12.4 Eco-friendly Initiatives
  • 3.13 Carbon Footprint Considerations

Chapter 4. Competitive Landscape, 2025

  • 4.1 Introduction
  • 4.2 Company market share analysis
    • 4.2.1 By region
      • 4.2.1.1 North America
      • 4.2.1.2 Europe
      • 4.2.1.3 Asia Pacific
      • 4.2.1.4 LATAM
      • 4.2.1.5 MEA
  • 4.3 Company matrix analysis
  • 4.4 Competitive analysis of major market players
  • 4.5 Competitive positioning matrix
  • 4.6 Key developments
    • 4.6.1 Mergers & acquisitions
    • 4.6.2 Partnerships & collaborations
    • 4.6.3 New Product Launches
    • 4.6.4 Expansion Plans

Chapter 5. Market Estimates and Forecast, By Source Type, 2025 - 2035 (USD Million, Kilo Tons)

  • 5.1 Key trends
  • 5.2 Egg white hydrolysates
    • 5.2.1 High-purity protein formulations
    • 5.2.2 Allergen-reduced variants
  • 5.3 Egg yolk hydrolysates
    • 5.3.1 Phospholipid-rich peptides
    • 5.3.2 Lipoprotein-functional blends
  • 5.4 Whole egg hydrolysates
    • 5.4.1 Balanced amino acid profile
    • 5.4.2 General-purpose formulations

Chapter 6. Market Estimates and Forecast, By Process, 2025 - 2035 (USD Million, Kilo Tons)

  • 6.1 Key trends
  • 6.2 Enzymatic hydrolysis
  • 6.3 Acid hydrolysis
  • 6.4 Other methods

Chapter 7. Market Estimates and Forecast, By Form, 2025 - 2035 (USD Million, Kilo Tons)

  • 7.1 Key trends
  • 7.2 Powder
  • 7.3 Liquid
  • 7.4 Capsules/Tablets

Chapter 8. Market Estimates and Forecast, By Application, 2025 - 2035 (USD Million, Kilo Tons)

  • 8.1 Key trends
  • 8.2 Nutraceuticals
    • 8.2.1 Digestive health
    • 8.2.2 Immune support
    • 8.2.3 Anti-inflammatory functionality
  • 8.3 Sports nutrition
    • 8.3.1 Pre-workout formulations
    • 8.3.2 Post-workout recovery formulations
    • 8.3.3 Muscle recovery peptides
  • 8.4 Infant & elderly nutrition
    • 8.4.1 Hypoallergenic protein blends
    • 8.4.2 Easily digestible amino profiles
  • 8.5 Clinical nutrition
    • 8.5.1 Tube-feeding solutions
    • 8.5.2 Recovery diets
  • 8.6 Functional food & beverages
    • 8.6.1 Bakery mixes
    • 8.6.2 Dairy and non-dairy beverages
  • 8.7 Cosmetics & personal care
    • 8.7.1 Anti-aging skincare
    • 8.7.2 Moisturizing applications
    • 8.7.3 Barrier-repair formulations

Chapter 9. Market Estimates and Forecast, By Region, 2025 - 2035 (USD Million, Kilo Tons)

  • 9.1 Key trends
  • 9.2 North America
    • 9.2.1 U.S.
    • 9.2.2 Canada
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 France
    • 9.3.4 Italy
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 China
    • 9.4.2 India
    • 9.4.3 Japan
    • 9.4.4 Australia
    • 9.4.5 South Korea
    • 9.4.6 Rest of Asia Pacific
  • 9.5 Latin America
    • 9.5.1 Brazil
    • 9.5.2 Mexico
    • 9.5.3 Argentina
    • 9.5.4 Rest of Latin America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 South Africa
    • 9.6.3 UAE
    • 9.6.4 Rest of Middle East & Africa

Chapter 10. Company Profiles

  • 10.1 Kewpie Corporation
  • 10.2 Bouwhuis Enthoven BV
  • 10.3 Merck KGaA
  • 10.4 Rose Acre Farms
  • 10.5 Rembrandt Foods
  • 10.6 Sanovo Technology Group
  • 10.7 Ovostar Union
  • 10.8 Pulviver
  • 10.9 IGRECA
  • 10.10 Taiyo Kagaku Co., Ltd.
  • 10.11 Bioseutica
  • 10.12 Deb-El Food Products
  • 10.13 AgroAlta
  • 10.14 EW Group
  • 10.15 Ballas Egg
  • 10.16 Eurovo Srl
  • 10.17 Crystal Lake Farms
  • 10.18 Farm Pride Foods
  • 10.19 Dalian Hanovo Foods
  • 10.20 SOVIMO HELLAS S.A.